Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanoma.

Melanoma research - 1 Aug 2026

Scala Marcella, Lorente-Estellés David, Liguori Luigi, Juan-Fita María José, De Nicola Emanuela, García-Casado Zaida, Traves Victor, Moro Ruggero, Requena Celia, Kumar Rajiv, Formisano Luigi, Nagore Eduardo

Abstract excerpt

Stage IIB-IIC cutaneous melanomas carry a substantial risk of recurrence and disease-related mortality despite complete surgical excision, highlighting the need for reliable prognostic biomarkers. We retrospectively analyzed 153 patients with stage IIB-IIC cutaneous melanoma who underwent surgery at the Instituto Valenciano de Oncología between May 2000 and August 2024. Recurrence-free survival (RFS),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Melanoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Receptor, Melanocortin, Type 1

Share to Skin Neoplasms

Share to Telomerase

Source

Identifiers

PMID: 42301209
DOI: 10.1097/CMR.0000000000001113

Genes

TERT
MC1R

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanoma.PMID 42301209Read ↗

Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort.Semantic proximity Read ↗

TERT promoter mutation subtypes and survival in stage I and II melanoma patients.Semantic proximity Read ↗

TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis.Semantic proximity Read ↗

TERT expression is associated with metastasis from thin primaries, exhausted CD4+ T cells in melanoma and with DNA repair across cancer entities.Semantic proximity Read ↗

Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features.Semantic proximity Read ↗

<scp><i>TERT</i></scp> promoter mutations in melanoma survivalSemantic proximity Read ↗

Melanoma risk loci as determinants of melanoma recurrence and survival.Semantic proximity Read ↗

TERT Promoter Mutations and Telomerase in MelanomaSemantic proximity Read ↗

TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.Semantic proximity Read ↗

Using deep learning to decipher the impact of telomerase promoter mutations on the dynamic metastatic morpholome.Semantic proximity Read ↗

Genetic Variants in WNT2B and BTRC Predict Melanoma Survival.Semantic proximity Read ↗

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.